Neomix-Pamine Solution .25 mg Liquid is a Health Canada–registered veterinary drug (DIN 00883034) held by The Upjohn Company - Animal Health Division, containing Methscopolamine Bromide. Health Canada lists its status as Cancelled Post Market (status date 28 Jul 1997). Nexara Health has matched 20 registrations of Methscopolamine Bromide across 2 other regulated markets.
Health Canada registration
| DIN | 00883034 |
|---|---|
| Brand name | Neomix-Pamine Solution |
| Active ingredient | Methscopolamine Bromide |
| Strength | .25 mg |
| Dosage form | Liquid |
| Route | Oral |
| Company | The Upjohn Company - Animal Health Division |
| Status | Cancelled Post Market — 28 Jul 1997 |
| Class | Veterinary |
| ATC | |
| AHFS | 40:34.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Methscopolamine Bromide registered in other markets
20 registrations of the same molecule in 2 national registries outside Canada (first 15 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Ace Tablets | Ono Pharmaceutical Co. Ltd. | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Buscon S.c. Tablets "N.c.p." | 正和製藥股份有限公司新營廠 | 錠劑 | Registered | TFDA | |
| Taiwan | Holopon Injection | Byk Gulden Lomberg Chemische Fabrik GmbH | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Holopon Tablets | Byk Gulden Lomberg Chemische Fabrik GmbH | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Holopon Tablets | Byk Gulden Lomberg Chemische Fabrik GmbH | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Pamine | Pharmacia & Upjohn Company | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Scopolamine Methylbromide "Boehringer" | Boehringer Ingelheim Pharma Kg | （粉） | 已註銷 | TFDA | |
| United States | Methscopolamine Bromide | Alchem International Private Ltd | Powder | FDA NDC | ||
| United States | Methscopolamine Bromide | Breckenridge Pharmaceutical, Inc. | Tablet | listed | FDA NDC | |
| United States | Methscopolamine Bromide | Phytex Australia Pty Ltd | Powder | FDA NDC | ||
| United States | Methscopolamine Bromide | Breckenridge Pharmaceutical, Inc. | Tablet | listed | FDA NDC | |
| United States | Methscopolamine Bromide | Unichem Pharmaceuticals (USA), Inc. | Tablet | listed | FDA NDC | |
| United States | Methscopolamine Bromide | PD-Rx Pharmaceuticals, Inc. | Tablet | listed | FDA NDC | |
| United States | Methscopolamine Bromide | PD-Rx Pharmaceuticals, Inc. | Tablet | listed | FDA NDC | |
| United States | Methscopolamine Bromide | Professional Compounding Centers of America dba PCCA | Powder | FDA NDC |
See every manufacturer of Methscopolamine Bromide worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Neomix-Pamine Solution (DIN 00883034) marketed in Canada?
No. Health Canada lists DIN 00883034 as Cancelled Post Market as of 28 Jul 1997.
Who holds the Canadian licence for this product?
The Upjohn Company - Animal Health Division is the company of record in the Health Canada Drug Product Database.
Is Methscopolamine Bromide registered outside Canada?
Yes — Nexara Health has matched 20 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00883034, status date 1997-07-28; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00883034, status date 1997-07-28; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 00883034, status date 1997-07-28; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.